ARTAX Trademark

Trademark Overview

On Thursday, May 28, 2020, a trademark application was filed for ARTAX with the United States Patent and Trademark Office. The USPTO has given the ARTAX trademark a serial number of 88936986. The federal status of this trademark filing is REGISTERED as of Tuesday, August 2, 2022. This trademark is owned by ARTAX BIOPHARMA, INC.. The ARTAX trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development in the pharmaceutical and biotechnology fields
artax

General Information

Serial Number88936986
Word MarkARTAX
Filing DateThursday, May 28, 2020
Status700 - REGISTERED
Status DateTuesday, August 2, 2022
Registration Number6809497
Registration DateTuesday, August 2, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 6, 2020

Trademark Statements

Name/Portrait Description and/or Consent StatementThe name shown in the mark does not identify a particular living individual.
Goods and ServicesResearch and development in the pharmaceutical and biotechnology fields

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, June 17, 2020
Primary Code042
First Use Anywhere DateWednesday, June 30, 2021
First Use In Commerce DateWednesday, June 30, 2021

Trademark Owner History

Party NameARTAX BIOPHARMA, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142
Party NameARTAX BIOPHARMA, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142
Party NameARTAX BIOPHARMA, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events

Event DateEvent Description
Tuesday, August 2, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, August 2, 2022REGISTERED-PRINCIPAL REGISTER
Friday, July 1, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, June 30, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, June 29, 2022STATEMENT OF USE PROCESSING COMPLETE
Wednesday, June 1, 2022USE AMENDMENT FILED
Friday, June 17, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, June 1, 2022TEAS STATEMENT OF USE RECEIVED
Thursday, December 2, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 30, 2021SOU EXTENSION 2 GRANTED
Tuesday, November 30, 2021SOU EXTENSION 2 FILED
Tuesday, November 30, 2021TEAS EXTENSION RECEIVED
Saturday, May 29, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 27, 2021SOU EXTENSION 1 GRANTED
Thursday, May 27, 2021SOU EXTENSION 1 FILED
Thursday, May 27, 2021TEAS EXTENSION RECEIVED
Tuesday, December 1, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 6, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 6, 2020PUBLISHED FOR OPPOSITION
Wednesday, September 16, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, August 31, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, August 31, 2020EXAMINER'S AMENDMENT ENTERED
Monday, August 31, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, August 31, 2020EXAMINERS AMENDMENT E-MAILED
Monday, August 31, 2020EXAMINERS AMENDMENT -WRITTEN
Monday, August 31, 2020ASSIGNED TO EXAMINER
Wednesday, June 17, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, June 1, 2020NEW APPLICATION ENTERED IN TRAM

Related Keywords

artax fields biotechnology pharmaceutical development research